Effects of two different hydroxyethyl starch solutions (HES200/0.5 vs. HES130/0.4) on the expression of platelet membrane glycoprotein

Acta Anaesthesiologica Scandinavica

Volumn 50, Issue 9, 2006, Pages 1089-1094

  Chen, G ^a   Yan, M ^a   Lu, Q H ^a   Gong, M ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

CD42b; CD61 41; CD62p; Flow cytometry; HES130 0.4; HES200 0.5; Hydroxyethyl starch; Platelet membrane glycoprotein

Indexed keywords

ADENOSINE DIPHOSPHATE; ATROPINE; CD61 ANTIGEN; DIAZEPAM; FENTANYL; FIBRINOGEN RECEPTOR; GLYCOPROTEIN; GLYCOPROTEIN IB ALPHA; HEMOGLOBIN; HETASTARCH; HETASTARCH 130; ISOFLURANE; MEMBRANE PROTEIN; MIDAZOLAM; PADGEM PROTEIN; PROPOFOL; RINGER LACTATE SOLUTION; UNCLASSIFIED DRUG; VECURONIUM;

ADULT; ARTICLE; BLEEDING; BLOOD CLOTTING; CHOLECYSTECTOMY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTIVE SURGERY; FEMALE; FLOW CYTOMETRY; HEMOGLOBIN DETERMINATION; HUMAN; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PAROTIDECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SURGICAL PATIENT;

ADENOSINE DIPHOSPHATE; ADULT; ANESTHESIA; BLOOD PLATELETS; CELL MEMBRANE; FEMALE; FLOW CYTOMETRY; GLYCOPROTEINS; HETASTARCH; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; P-SELECTIN; PLASMA SUBSTITUTES; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;

EID: 33748938721     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2006.01138.x     Document Type: Article

References (27)

1. Sander O, Reinhart K, Meier-Hellmann A. Equivalence of hydroxyethyl starch HES 130/0.4 and HES 200/0.5 for perioperative volume replacement in major gynaecological surgery. Acta Anaesthesiol Scand 2003; 47: 1151-8.
2. Kasper SM, Dahlmann H, Mellinghoff H, et al. Lactated Ringer's solution versus hydroxyethyl starch for volume replacement in autologous blood donors with cardiovascular disease: a controlled, randomized trial. Vox Sang 1998; 75: 26-31.
3. Niemi TT, Kuitunen AH. Hydroxyethyl starch impairs in vitro coagulation. Acta Anaesthesiol Scand 1998; 42: 1104-9.
4. Jamnicki M, Bombeli T, Seifert B, et al. Low- and medium-molecular-weight hydroxyethyl starches: comparison of their effects on blood coagulation. Anaesthesiology 2000; 93: 1231-7.
5. Felfernig M, Franz A, Braeunlich P, et al. The effects of hydroxyethyl starch solutions on thromboelastography. Acta Anaesthesiol Scand 2002; 47: 70-3.
6. Niemi TT, Kuitunen AH. Artificial colloids impair haemostasis. An in vitro study using thromboelastometry coagulation analysis. Acta Anaesthesiol Scand 2005; 49: 373-8.
7. Konrad CJ, Markl TJ, Schuepfer GK, et al. In vitro effects of different medium molecular hydroxyethyl starch solutions and lactated Ringer's solution on coagulation using SONO-CLOT. Anesth Analg 2002; 90: 274-9.
8. Chong Sung K, Kum Suk P, Mi Ja Y, et al. Effects of intravascular volume therapy using hydroxyethyl starch (130/0.4) on post-operative bleeding and transfusion requirements in children undergoing cardiac surgery: a randomized clinical trial. Acta Anaesthesiol Scand 2006; 50: 108-11.
9. Shan C, Wu GL, Zhang S, et al. Effect of acute hypervolemic hemodilution on expression of CD62P and CD63 on platelet. Chin J Anesthesiol 2003; 23: 648-50.
10. Michelson AD. Flow cytometry: a clinical test of platelet function. Blood 1996; 87: 4925-36.
11. Thomas S, Metcalfe P, Goodall AH, et al. Monoclonal antibodies against platelet membrane glycoproteins IIb/IIIa and Ibalpha inhibit platelet dependent thrombin generation by different mechanisms. Thromb Haemost 2000; 84: 98-103.
12. Wang JZ, Cao L, Yuan JY, et al. Study on the action of three kinds of anti-platelet drugs for in vitro inhibiting platelet activation. Chin J Lab Med 2002; 25: 8-11.
13. Stogermuller B, Stark J, Willschke H, et al. The effect of hydroxyethyl starch 200 kD on platelet function. Anesth Analg 2000; 91: 823-7.
14. Berndt MC, Shen Y, Dopheide SM, Gardiner EE, Andrews RK. The vascular biology of the glycoprotein Ib-IX-V complex. Thromb Haemost 2001; 86: 178-88.
15. Canobbio I, Balduini C, Torti M. Signaling through the platelet glycoprotein Ib-V-IX complex. Cell Signal 2004; 16: 1329-44.
16. Caron A, Theoret JF, Mousa SA, et al. Anti-platelet effects of GPIIb/IIIa and P-selectin antagonism, platelet activation, and binding to neutrophils. J Cardiovasc Pharmacol 2002; 40: 296-306.
17. Nielsen VG. Effects of PentaLyte and Voluven hemodilution on plasma coagulation kinetics in the rabbit: role of thrombin-fibrinogen and factor XIII-fibrin polymer interactions. Acta Anaesthesiol Scand 2005; 49: 1263-71.
18. Larson E, Celi A, Gilbert G. PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 1989; 59: 305-12.
19. Gamsjager T, Gustorff B, Kozek-Langenecker S. Effect of hydroxyethyl starches on intracelluar calcium in platelet. Anesth Analg 2002; 94: 866-9.
20. Deusch E, Thaler U, Kozek-Langenecker SA. The effects of high molecular weight hydroxyethyl starch solutions on platelets. Anesth Analg 2004; 99: 665-8, table of contents.
21. Nielsen VG. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions. Acta Anaesthesiol Scand 2005; 49: 1163-71.
22. Ruttmann T, James M, Aronson I. In vivo investigation into the effect of hemodilution with hydroxyethyl starch (200/0.5) and normal saline on coagulation. Br J Anaesth 1998; 80: 612-6.
23. Kapiotis S, Quehenberger P, Eichler H, et al. Effect of hydroxyethyl starch on the activity of blood coagulation and fibrinolysis in healthy volunteers: comparison with albumin. Crit Care Med 1994; 22: 606-12.
24. Conroy J, Fishman R, Reeves R, et al. The effect of desmopressin and 6% hydroxyethyl starch on factor VIII:C. Anesth Analg 1996; 83: 804-7.
25. Felfernig M, Franz A, Braunlich P, et al. The effects of hydroxyethyl starch solutions on thromboelastography in preoperative male patients. Acta Anaesthesiol Scand 2003; 47: 70-3.
26. Entholzner EK, Mielke LL, Calatzis AN, et al. Coagulation effects of a recently developed hydroxyethyl starch (HES 130/0.4) compared to hydroxyethyl starches with higher molecular weight. Acta Anaesthesiol Scand 2000; 44: 1116-21.
27. Franz A, Braunlich P, Gamsjager T, et al. The effects of hydroxyethyl starches of varying molecular weights on platelet function. Anesth Analg 2001; 92: 1402-7.